Monday, September 6, 2010





























Monday, August 30, 2010

CONCLUSION

CONCLUSION
Three-dimensional echocardiography is a safe, noninvasive
imaging modality that is complementary and
supplementary to 2D imaging and can be used to
assess cardiovascular function and anatomy in various
clinical settings. At present, available evidence suggests
that 3D echocardiography provides improved
accuracy and reproducibility over 2D methods for LV
volume and function calculation and the derivation of
mitral valve area in patients with mitral stenosis. Further
technological improvements and additional clinical
studies will broaden the list of appropriate applications
for this exciting new ultrasound modality.

FUTURE DIRECTIONS

FUTURE DIRECTIONS
Ongoing developments in 3D echocardiography
include technological innovations and expanding
clinical applications. Automated surface extraction
and quantification, single-heartbeat full-volume
acquisition, transesophageal RT3D imaging,
the ability to navigate within the 3D volume, and
stereoscopic visualization of 3D images are some
of the technological advances that can be expected
over the next several years. These will
further enhance the quality and clinical applications
of 3D echocardiography. In addition, standardized
and focused 3D protocols will be developed
and refined to optimize clinical application
of this technique.
Tagging and/or tracking the LV surface in real
time may provide new approaches to quantifying
myocardial mechanics, such as regional shape and
strain. This approach has great potential and will
complement and likely compare favorably with
the quantitative ability of cardiac MRI. The superior
temporal resolution of echocardiography
should offer unique advantages for this purpose.
In the future, combining the greater temporal
resolution of 3D echocardiography with the excellent
spatial resolution of MRI (or computed
tomography) may yield an imaging data set with

FUTURE DIRECTIONS
Ongoing developments in 3D echocardiography
include technological innovations and expanding
clinical applications. Automated surface extraction
and quantification, single-heartbeat full-volume
acquisition, transesophageal RT3D imaging,
the ability to navigate within the 3D volume, and
stereoscopic visualization of 3D images are some
of the technological advances that can be expected
over the next several years. These will
further enhance the quality and clinical applications
of 3D echocardiography. In addition, standardized
and focused 3D protocols will be developed
and refined to optimize clinical application
of this technique.
Tagging and/or tracking the LV surface in real
time may provide new approaches to quantifying
myocardial mechanics, such as regional shape and
strain. This approach has great potential and will
complement and likely compare favorably with
the quantitative ability of cardiac MRI. The superior
temporal resolution of echocardiography
should offer unique advantages for this purpose.
In the future, combining the greater temporal
resolution of 3D echocardiography with the excellent
spatial resolution of MRI (or computed
tomography) may yield an imaging data set with

Contrast Echocardiography

Contrast Echocardiography
The use of contrast with 3D echocardiography to
improve quantification of LV volumes offers several
advantages. The RT3D technique (single or
full volume) provides the most practical approach.
Triggering, although not essential, increases
the signal-to-noise ratio and thus is superior
to nontriggered imaging.38 Preliminary
clinical studies have shown promise with regard
to improved LV surface identification and volume
and ejection fraction measurement.129,130
Another evolving application of contrast 3D
echocardiography is in the evaluation of myocardial
perfusion. The ability to record the entire LV
and to quantify the full extent of hypoperfused
myocardium is a potential advantage of this approach.
131-133 However, the problem of microbubble
destruction, even with triggered imaging,
remains a challenge. This is especially true when
matrix array transducers are used, which results in
suboptimal myocardial opacification due to high
acoustic power. Further technological developments
should lead to improvements in all of these
areas and will contribute to more practical applications
of contrast 3D echocardiography.

Intraoperative Applications

Intraoperative Applications
The accuracy, feasibility, and value of 3D echocardiography
also have been demonstrated in the
intraoperative environment. Intraoperative 3D
echocardiography provides accurate and often
additional anatomic information compared with
2D transesophageal (TEE) imaging.123 In limited
studies examining 2D and 3D TEE intraoperative
evaluation of mitral valve prolapse anatomy, 3D
TEE evaluation provided complementary and additional
information compared with 2D TEE for
localization of prolapsed scallops (video clip
14).77,124 Intraoperative 3D TEE also has been
used to identify distortion and folding of the mitral
annulus as a cause of functional mitral stenosis or
worsening mitral regurgitation during beatingheart
surgery.125 Finally, intraoperative 3D TEE
has proven valuable in patients undergoing surgery
for congenital heart lesions. For example, the
superiority of intraoperative 3D TEE compared
with 2D has been demonstrated by its ability to
provide en face and oblique views of left atrioventricular
valve malformations in patients undergoing
reoperation for persistent regurgitant lesions
after previous repair of atrioventricular septal
defects.78,126
Intraoperative epicardial RT3D echocardiography
has been used to improve spatial orientation
and assess the extent of septal thickening, mitral
valve systolic anterior motion, and postsurgical LV
outflow tract patency in a patient with hypertrophic
cardiomyopathy undergoing septal myectomy,.
127 It also has been used to guide and monitor
off-pump atrial septal defect closure in a beatingheart
animal model.128 Finally, intraoperative epicardial
and postoperative transthoracic RT3D
echocardiography has been used to evaluate
changes in LV volume and function during cardiac
surgery in patients undergoing infarct exclusion
surgery for ischemic cardiomyopathy.69 In contrast
to 3D echocardiographic imaging, conventional
2D methods may not accurately quantify LV
volumes in patients with severe ischemic cardio

cardiomyopathy,
especially in the presence of significant
geometric changes due to LV aneurysm.

Congenital Heart Disease

Congenital Heart Disease
Clinical investigations examining the role of 3D echocardiography
in patients with congenital heart disease
have emphasized the unique perspective provided by
3D imaging and the versatility of the technique in

patients with simple defects or complex conditions
and in the postoperative state.115,116 Three-dimensional
echocardiography, using both reconstruction
methods and RT3D, has been used to detect several
forms of congenital heart disease. The ability to record
and analyze the entire cardiac structure and the ability
to display complex spatial relationships are potential
advantages of 3D imaging over 2D echocardiography.
In addition, the decreased examination time afforded
by RT3D echocardiography may reduce the need for
sedation in some children.116
In patients with atrial septal defects, 3D echocardiography
can record the size and shape of the defect. It
also can show the precise location of the defect and
the extent of residual surrounding tissue. In patients
with secundum atrial septal defects (Figure 11, video
clip 13), the extent of the retroaortic rim often determines
the feasibility of repair with percutaneous closure
devices. Three-dimensional echocardiography
also has been used after atrial septal defect closure to
evaluate the success of the procedure and identify the
origin of residual shunting.117 In patients with ventricular
septal defects, the ability to interrogate the entire
septum is frequently cited as an advantage of the 3D
technique.118,119 A novel application of 3D imaging in
patients with ventricular septal defects involves using
offline reconstruction to measure the shape and size of
the color flow jet, which allows for accurate measurement
of the magnitude of shunting in patients with
isolated ventricular septal defects.119
Various 3D echocardiographic techniques have
been used to evaluate RV and LV size and function in
patients with congenital heart disease. The approach
to the LV is similar to that described previously and
permits quantification of dimension, volume, mass,
and ejection fraction.120 Owing to the ellipsoidal shape
of the LV, the advantages of 3D over 2D echocardiographic
techniques are limited, because simple geometric
assumptions can be used to calculate LV volumes;
however, the RV’s asymmetrical shape
invalidates the simple geometric assumptions used for
LV volume calculations. In this case, the ability to
record and analyze the entire chamber rather than
relying on simplifying assumptions has proven
superior.48 In patients with congenital heart diseases
that involve RV pathology, 3D echocardiography correlates
well with MRI for the measurement of RV
volume.48,121,122
Three-dimensional echocardiography has been
successfully applied to the detection and assessment
of several anatomic defects. For example,
the circumferential extent and severity of discrete

subaortic membranes have been successfully visualized
with 3D echocardiography.119,120 With the
apical view, a unique en face image of the membrane
can be recorded, which permits analysis of
the effective orifice area and the dynamic nature
of the defect. Congenital malformations of the
mitral valve also have been assessed with 3D
echocardiography.80 The complex nature of these
defects can make a thorough anatomic evaluation
difficult. In such cases, the perspective provided
by 3D echocardiography can provide a complete
preoperative assessment of the extent and severity
of the valvular abnormality.

Valvular Heart Disease

Valvular Heart Disease
The recent widespread availability of RT3D echocardiography
obviates many of the practical limitations of
reconstructive 3D techniques and offers the potential
for greater clinical application for valvular heart disease
both in standard diagnostic evaluation and in
real-time guidance during surgical valve repair. This
technique is ideally suited for assessing valve function
given the nonplanar anatomy of the cardiac valves and
the associated anatomic and spatial alterations associated
with valvular heart disease.
Mitral Valve. The 3D echocardiography technique
has contributed significantly to our understanding of
mitral valve function and anatomy. The mitral valve is
particularly suited to 3D assessment because of the
complex interrelationships among the valve, chordae,
papillary muscles, and myocardial walls. This technique
can provide important insight into mitral valve
structure, demonstrating the saddle shape of the mitral
annulus, with high points located anteriorly and low
points oriented in a mediolateral direction (Figure 10,
video clip 8). This has helped clarify the appropriate

diagnostic imaging planes from which mitral valve
prolapse should be diagnosed, thereby avoiding falsepositive
interpretations.64,65
In addition, 3D echocardiography has provided important
mechanistic insights into functional and ischemic
mitral regurgitation resulting from derangements
of the normal spatial relationships of the mitral valve
leaflets to its chordal attachments, papillary muscles,
and the LV.13,66 Distortion of the normal spatial relationship
between the LV and mitral valve apparatus
results in papillary muscle displacement and tethering
of the mitral leaflets, leading to incomplete closure of
the leaflets and mitral regurgitation (video clip 9). The
3D echocardiography technique has identified
changes in annular shape occurring with functional
mitral regurgitation.67-69 These mechanistic and anatomic
insights based on 3D analysis have provided the
basis for the development of new approaches to
treating ischemic mitral regurgitation.70-74
Three-dimensional echocardiography has been used
to define and localize mitral leaflet lesions in mitral
valve prolapse, endocarditis, and congenital mitral
abnormalities.75-80 This application has been particularly
important in guiding surgical repair (video clips
10 and 11).81-83
The RT3D approach has also demonstrated efficacy
in quantifying mitral regurgitation by using 3D guidance
to directly measure the proximal flow convergence
region.84,85 It has provided insight into how
premitral orifice geometry affects the calculation of
mitral valve area in mitral stenosis.86 Calculation of
mitral valve area by 3D echocardiography has been
demonstrated to be accurate, reproducible, and less
variable than conventional 2D methods 

and thus has been recommended as the firstline
method.92 In addition, 3D echocardiography has
been used for guidance during percutaneous mitral
valvuloplasty.93,94
Aortic Valve. Three-dimensional echocardiography
has been applied for anatomic assessment of the aortic
valve and root morphology and to calculate the valve
area in aortic stenosis.95-99 The technique has been
used to delineate aortic flow patterns100,101 and has
demonstrated feasibility and accuracy in quantifying
aortic regurgitation.102,103 Other applications have included
the detection and localization of aortic valve
vegetations, assessment of congenital outflow obstruction
abnormalities, and demonstration of morphological
changes in the valve after balloon dilation.103-107
Tricuspid and Pulmonary Valves. Compared with
the aortic and mitral valves, the tricuspid and pulmonary
valves have been less widely studied with 3D
echocardiography. This technique has demonstrated
anatomic changes with rheumatic and degenerative
tricuspid valve disease.108-110 and has accurately reconstructed
congenital tricuspid valve abnormalities, such
as atrioventricular canal defects.111,112 For the pulmonary
valve, 3D assessment has been limited to descriptive
case reports defining anatomic abnormalities associated
with pulmonary valve stenosis and
endocarditis